Siamycin I, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ136)

Product Quick View

Siamycin I (BMY-29304), a 21-residue tricyclic peptide, is a secondary metabolite in actinomycetes. Siamycin I is a HIV fusion inhibitor with ED50s of 0.05 to 5.7 μM for acute HIV type 1 (HIV-1) and HIV-2 infections. Siamycin I inhibits the gelatinase and gelatinase biosynthesis-activating pheromone (GBAP) signaling via the FsrC-FsrA two-component regulatory system in a noncompetitive manner. Siamycin I suppresses the expression of both fsrBDC and gelE-sprE transcripts. Siamycin I, a lasso peptide, interacts with lipid II and inhibits cell wall biosynthesis. Siamycin I, an antibiotic, has the potential for enterococcal infections research.

Overview
SynonymsBMY-29304; Siamycin I; Siamycin
SourceBacteria
ActivityVirus; HIV; Gram-positive bacteria; Envelope virus; Fusion
Physical StatePowder
Purity>98%
StorageThe power can be stored at 4°C for 2 years or at -20°C for 3 years.

For Research Use Only.

Related products
Online Inquiry
Name:
Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.